FIELD: medicine. SUBSTANCE: new medicinal agent consists of a mixture of equal amounts of heparin and chitosan sulfoester at viscosity 0.2-0.4 dl/g and sulfur content 13.0-15.0% and exhibits direct anticoagulating effect. At intravenous administration new agent provides decrease of heparin consumption and its hemorrhagic action at the retained antithrombic and anticoagulant activities. Agent can be used for thrombosis prophylaxis and treatment. EFFECT: enhanced effectiveness of agent. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTICOAGULATION DRUG | 1996 |
|
RU2146138C1 |
ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 |
|
RU2571555C1 |
AGENT WITH ANTITHROMBOTIC ACTIVITY | 2016 |
|
RU2627435C1 |
SYNTHETIC PEPTIDE DERIVATIVE EXPRESSING ANTICOAGULANT ACTIVITY | 2007 |
|
RU2377246C2 |
AGENT SHOWING ANTIAGGREGATION ACTIVITY | 1990 |
|
RU2033791C1 |
ANTICOAGULATING BIOLOGICALLY ACTIVE COMPLEX MADE OF SIBERIAN CEDAR BARK | 2007 |
|
RU2366441C2 |
ANTICOAGULANT | 2009 |
|
RU2399377C1 |
ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
AGENT WITH ANTICOAGULATING EFFECT AND ITS APPLICATION METHOD | 2021 |
|
RU2799028C2 |
METHOD OF ASSAY OF PARVOVIRUS B 19 | 1998 |
|
RU2146372C1 |
Authors
Dates
1997-04-10—Published
1993-11-23—Filed